Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tuberculin PPD
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Equivalence Study of Specificity of PPD
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
February 25, 2013
Lead Product(s) : Tuberculin PPD
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Purified Protein Derivative
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 25, 2013
Lead Product(s) : Purified Protein Derivative
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aplisol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 21, 2012
Lead Product(s) : Aplisol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable